ArticleOncotarget2017

Expression of CD38 in myeloma bone niche: A rational basis for the use of anti-CD38 immunotherapy to inhibit osteoclast formation.

Federica Costa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.